February 20, 2014 -- Pall Corporation (NYSE:PLL), a global leader in filtration, separation and purification, today announced it has completed the acquisition of the LifeSciences business of ATMI, Inc. (NASDAQ-GS:ATMI). Click here to learn more… For more information about Pall’s Life Sciences products and services, visit www.pall.com or contact us.

Leading the Way in Advanced
Single-Use Technologies

Pall LifeSciences is the source of bioprocess efficiency to its biopharmaceutical customers, providing a broad range of innovative single-use mixing, storage, powder transfer, packaging and bioreactor technology solutions that maximize product integrity while optimizing manufacturing cost.

Integrity™ TK8 Film: One-Film Platform

Integrity™ branded products are made from the same TK8 film so all product-contact areas are identical. This approach simplifies qualification and validation efforts and reduces overall costs.

Learn More About TK8 Film